|
Issue |
Title |
|
Vol 23, No 2 (2022): VOLUME 23, NUMBER 2, August 2022 |
Use of Biologics in Inflammatory Bowel Disease: Combination and Sequential Therapy |
Abstract
PDF
|
Putra Nur Hidayat, Marcellus Simadibrata |
|
Vol 23, No 3 (2022): VOLUME 23, NUMBER 3, December 2022 |
Clinical and Endoscopic Improvement of Inflammatory Bowel Disease with Curcumin Therapy: Experiences from Clinical Studies |
Abstract
PDF
|
William Suciangto, Munaiva Syahrir |
|
Vol 20, No 1 (2019): VOLUME 20, NUMBER 1, April 2019 |
Inflammatory Bowel Disease in Young Adult |
Abstract
PDF
|
Dian Daniella, Janto Simkoputera, Candra Wiguna |
|
Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024 |
Complications of Immunomodulator and Mesalazine Therapy in Crohn’s Disease |
Abstract
PDF
|
Kaka Renaldi, Fransiscus Nikodemus Hosea |
|
Vol 21, No 2 (2020): VOLUME 21, NUMBER 2, August 2020 |
Current Role of Anti-Integrin Therapy in Inflammatory Bowel Disease |
Abstract
PDF
|
Kevin Winston, Hasan Maulahela, Lusiani Lusiani, Raditya Dewangga, Lazuardi G Ilhami |
|
Vol 18, No 3 (2017): VOLUME 18, NUMBER 3, DECEMBER 2017 |
The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease |
Abstract
PDF
|
Tri Hapsoro Guno, Marcellus Simadibrata |
|
Vol 22, No 3 (2021): VOLUME 22, NUMBER 3, December 2021 |
A Crohn’s Disease Patient with Extraintestinal Manifestations: A Case Report |
Abstract
PDF
|
Yhan Batista, Herry Purbayu |
|
Vol 23, No 1 (2022): VOLUME 23, NUMBER 1, April 2022 |
Vaccination for Inflammatory Bowel Disease Patients |
Abstract
PDF
|
Evy Yunihastuti |
|
1 - 8 of 8 Items |
|